Literature DB >> 9261472

Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.

J J Li1, Y Q Huang, C J Cockerell, W G Zhang, A Nicolaides, A E Friedman-Kien.   

Abstract

Alteration of the p53 gene is the most frequent event reported in human cancer, and p53 mutations have been observed in various neoplasms, including certain forms of skin cancer. Therefore, we postulated that p53 may also be involved in Kaposi's sarcoma associated with AIDS (AIDS-KS). Expression of the p53 gene was examined in freshly isolated tumor biopsy specimens from 15 patients with AIDS-KS. p53 mRNA was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in both the AIDS-KS tumors and in normal skin control samples. p53 protein was detected in 4 of the 15 AIDS-KS specimens by immunohistochemical staining. Single-strand conformation polymorphism analysis PCR-products (PCR-SSCP) was used for detection of mutations of the p53 gene. One of the p53 positive AIDS-KS samples showed mobilized shifts in exon 6 suggestive of a mutation. Sequencing data showed the mutation to be located in codon 210. We examined other mechanisms that could stabilize p53 protein. SV40 large T antigen and adenovirus E1B protein were not found in the AIDS-KS specimens. MDM2, a p53-binding protein, was also detected in five of the AIDS-KS specimens, two of which also contained p53-positive cells. These observations suggest that the tumor suppressor gene p53 may be involved in the pathogenesis of AIDS-KS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261472     DOI: 10.1097/00000372-199708000-00009

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells.

Authors:  Takahiro Watanabe; Makoto Sugaya; April M Atkins; Elisabeth A Aquilino; Aparche Yang; Debra L Borris; John Brady; Andrew Blauvelt
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

3.  Bcl-2 and p53 immunoprofile in Kaposi's sarcoma.

Authors:  P Pillay; R Chetty; R Reddy
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 4.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

5.  Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression.

Authors:  M M Kennedy; J J O'Leary; J L Oates; S B Lucas; D D Howells; S Picton; J O McGee
Journal:  Mol Pathol       Date:  1998-06

6.  Kaposi sarcoma of the adrenal gland resembling epithelioid angiosarcoma: a case report.

Authors:  Hassan Huwait; Adam Meneghetti; Torsten O Nielsen
Journal:  Sarcoma       Date:  2011-08-09

Review 7.  Clonality, Mutation and Kaposi Sarcoma: A Systematic Review.

Authors:  Blanca Iciar Indave Ruiz; Subasri Armon; Reiko Watanabe; Lesley Uttley; Valerie A White; Alexander J Lazar; Ian A Cree
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

Review 8.  Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease.

Authors:  Jacqueline Fröhlich; Adam Grundhoff
Journal:  Semin Immunopathol       Date:  2020-03-26       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.